Litcius/Paper detail

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

Laura Mariani, Sean Eddy, Fadhl Alakwaa, Phillip J. McCown, Jennifer L. Harder, Viji Nair, Felix Eichinger, Sebastian Martini, Adebowale Ademola, Vincent Boima, Heather N. Reich, Jamal El Saghir, Bradley Godfrey, Wenjun Ju, Emily C. Tanner, Virginia Vega-Warner, Noel L. Wys, Sharon G. Adler, Gerald B. Appel, Ambarish M. Athavale, Meredith A. Atkinson, Serena M. Bagnasco, Laura Barisoni, E. Sherwood Brown, Daniel C. Cattran, Gaia Coppock, Katherine M. Dell, Vimal K. Derebail, Fernando C. Fervenza, Alessia Fornoni, Crystal A. Gadegbeku, Keisha L. Gibson, Laurence Greenbaum, Sangeeta Hingorani, Michelle Hladunewich, Jeffrey B. Hodgin, Marie C. Hogan, Lawrence B. Holzman, J. Ashley Jefferson, Frederick J. Kaskel, Jeffrey B. Kopp, Richard Lafayette, Kevin V. Lemley, John C. Lieske, Jen‐Jar Lin, Rajarasee Menon, Kevin Meyers, Patrick H. Nachman, Cynthia C. Nast, Michelle M. O’Shaughnessy, Edgar A. Otto, Kimberly J. Reidy, Kamalanathan K. Sambandam, John R. Sedor, Christine B. Sethna, Pamela Singer, Tarak Srivastava, Cheryl L. Tran, Katherine R. Tuttle, Suzanne Vento, Chia-shi Wang, Akinlolu Ojo, Dwomoa Adu, Debbie S. Gipson, Howard Trachtman, Matthias Kretzler

2022Kidney International89 citationsDOIOpen Access PDF

Topics & Concepts

Focal segmental glomerulosclerosisMinimal change diseaseMedicineNephrologyKidney diseaseInternal medicineHazard ratioKidneyOncologyPathologyGlomerulonephritisConfidence intervalRenal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesVasculitis and related conditions
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis | Litcius